MedTrace Logo

Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users

NCT02740582 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2020-09-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effects of tolcapone on decision making and alcohol intake using a laboratory bar (on-site alcohol self-administration) in alcohol drinkers.

Conditions

  • Alcohol Abuse
  • Impulsive Behavior

Interventions

DRUG

Tolcapone

DRUG

Placebo

Sponsors & Collaborators

  • Jennifer Mitchell

    lead OTHER

Principal Investigators

  • Jennifer Mitchell, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2019-09-01
Completion
2019-11-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02740582 on ClinicalTrials.gov